New indication in children from birth for Guerbet’s half-dose GBCA, Elucirem™ (Gadopiclenol) approved by European Commission
VILLEPINTE, France, Jan. 27, 2026 /PRNewswire/ — Guerbet (FR0000032526 GBT), a global specialist in contrast media and solutions for medical imaging, is delighted to announce the approval by European Commission of a
